Professor Robin Jones

Professor and Consultant Medical Oncologist at The Royal Marsden and Team Leader in Sarcoma Clinical Trials at The Institute of Cancer Research, UK.

Country

United Kingdom

Speciality

Oncology

Subspeciality

Bone and Soft Tissue Sarcomas

Experience

1994 years

Languages

English

Areas of expertise

Bone and Soft Tissue Sarcomas
Novel agents and Immunotherapy in Sarcomas

About the expert

Professor Jones is currently a Consultant Medical Oncologist at The Royal Marsden and Head of the Sarcoma Unit at The Royal Marsden and Team Leader in Sarcoma Clinical Trials at The Institute of Cancer Research, UK. He is currently working on a number of trials of investigational agents in sarcomas as well as laboratory-based studies with Dr. Paul Huang.

Professor Jones has contributed to 474 publications.

Prof. Robin completed his medical training at Guy’s and St Thomas’ Hospital and his oncology training at The Royal Marsden. His postgraduate research degree, with Professor Dowsett at the ICR, evaluated potential predictive and prognostic factors in breast cancer patients treated with neoadjuvant chemotherapy.

In January 2010 he was appointed Associate Professor and Director of the Sarcoma Program at the University of Washington and Fred Hutchinson Cancer Research Center in Seattle. He led a successful clinical and research program and continued his translational and trial-based research. The laboratory work with Dr. Seth Pollack evaluated novel immunotherapeutic targets in bone and soft tissue sarcomas, and has led to a number of early-phase immunotherapeutic clinical trials.

He returned to The Royal Marsden and Institute of Cancer Research in December 2014, as Sarcoma Clinical Trials Team Leader and Consultant Medical Oncologist. He has experience in conducting Phase I, II and III trials, as well as translational studies in sarcoma. He is continuing a number of trials of investigational agents as well as laboratory-based immunotherapy studies.

He is a member of the Sarcoma Alliance for Research through Collaboration (SARC) concept review committee, European Organization for Research and Treatment of Cancer (EORTC) Sarcoma Group, the American Joint Committee on Cancer (AJCC) soft tissue sarcoma staging panel. He has previously served on the American Society of Clinical Oncology (ASCO) Educational Committee and the National Comprehensive Cancer Network (NCCN) Bone Tumour Panel.

Consultant Medical Oncologist
2014 - Today
The Royal Marsden
Head of the Sarcoma Unit
2014 - Today
The Royal Marsden
Team Leader in Sarcoma Clinical Trials
2014 - Today
The Institute of Cancer Research
Associate Professor and Director of the Sarcoma Program
2010 - 2014
University of Washington and Fred Hutchinson Cancer Research Center in Seattle

Bachelor of Medicine and Bachelor of Surgery

Guy’s and St Thomas Hospital

2003

Sarcoma Alliance for Research through Collaboration (SARC) concept review committee
European Organization for Research and Treatment of Cancer (EORTC) Sarcoma Group
The American Joint Committee on Cancer (AJCC) Soft tissue Sarcoma Staging Panel
American Society of Clinical Oncology (ASCO) Educational Committee
National Comprehensive Cancer Network (NCCN) Bone Tumour Panel.

Other experts inthe same specialty

Doctor Premini Mahendra

Consultant Haemato-Oncologist, Birmingham, United Kingdom